Dana Flanders
Stock Analyst
(n/a)
# 4,425
Out of 4,433 analysts
8
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SCYX SCYNEXIS | Initiates: Buy | n/a | $2.41 | - | 1 | Jan 22, 2021 | |
| TRVN Trevena | Initiates: Buy | n/a | $0.41 | - | 1 | Sep 14, 2020 | |
| PCRX Pacira BioSciences | Initiates: Neutral | n/a | $31.51 | - | 1 | May 27, 2020 | |
| HRTX Heron Therapeutics | Initiates: Buy | n/a | $3.22 | - | 1 | May 27, 2020 | |
| COLL Collegium Pharmaceutical | Initiates: Neutral | n/a | $33.67 | - | 1 | May 27, 2020 | |
| LGND Ligand Pharmaceuticals | Initiates: Neutral | n/a | $85.02 | - | 2 | Mar 10, 2020 | |
| EBS Emergent BioSolutions | Upgrades: Buy | n/a | $5.27 | - | 1 | Nov 2, 2018 |
SCYNEXIS
Jan 22, 2021
Initiates: Buy
Price Target: n/a
Current: $2.41
Upside: -
Trevena
Sep 14, 2020
Initiates: Buy
Price Target: n/a
Current: $0.41
Upside: -
Pacira BioSciences
May 27, 2020
Initiates: Neutral
Price Target: n/a
Current: $31.51
Upside: -
Heron Therapeutics
May 27, 2020
Initiates: Buy
Price Target: n/a
Current: $3.22
Upside: -
Collegium Pharmaceutical
May 27, 2020
Initiates: Neutral
Price Target: n/a
Current: $33.67
Upside: -
Ligand Pharmaceuticals
Mar 10, 2020
Initiates: Neutral
Price Target: n/a
Current: $85.02
Upside: -
Emergent BioSolutions
Nov 2, 2018
Upgrades: Buy
Price Target: n/a
Current: $5.27
Upside: -